TickerFacts.

Protara Therapeutics, Inc. (TARA): Total Liabilities

Annual figures by period end, from SEC filings.

$13.06M
As of 2025-12-31
$14.78M
As of 2026-06-30
+5.2%
3-year compound annual growth
+27.2%
5-year compound annual growth
+12.2%
10-year compound annual growth
$14.32M2013-12-31: $9.77M2014-12-31: $2.34M2015-12-31: $4.13M2016-12-31: $5.08M2017-12-31: $9.24M2018-12-31: $3.08M2019-12-31: $3.35M2020-12-31: $3.91M2021-12-31: $10.68M2022-12-31: $11.21M2023-12-31: $10.63M2024-12-31: $14.32M2025-12-31: $13.06M$13.06M
2013-12-31 Total Liabilities (USD) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31$13.06M-8.8%2026-03-10, Balance as of period end
2024-12-31$14.32M+34.7%2026-03-10, Balance as of period end
2023-12-31$10.63M-5.1%2025-03-05, Balance as of period end
2022-12-31$11.21M+4.9%2024-03-13, Balance as of period end
2021-12-31$10.68M+172.9%2023-03-08, Balance as of period end
2020-12-31$3.91M+16.8%2022-03-09, Balance as of period end
2019-12-31$3.35M+8.9%2021-03-11, Balance as of period end
2018-12-31$3.08M-66.7%2020-03-20, Balance as of period end
2017-12-31$9.24M+81.9%2019-03-13, Balance as of period end
2016-12-31$5.08M+22.9%2018-03-14, Balance as of period end
2015-12-31$4.13M+76.8%2017-03-16, Balance as of period end
2014-12-31$2.34M-76.1%2016-03-14, Balance as of period end
2013-12-31$9.77Mn/a2015-03-20, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Biological Products, (No Diagnostic Substances)), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
Protara Therapeutics, Inc. (TARA)2025-12-31$13.06M-8.8%
Instil Bio, Inc. (TIL)2025-12-31$89.66M-4.8%
Compass Therapeutics, Inc. (CMPX)2025-12-31$22.80M+50.3%
Metagenomi Therapeutics, Inc. (MGX)2025-12-31$62.51M-30.3%
enGene Therapeutics Inc. (ENGN)2025-10-31$53.76M+39.4%
Century Therapeutics, Inc. (IPSC)2025-12-31$64.77M-66.2%
TScan Therapeutics, Inc. (TCRX)2025-12-31$105.67M-18.8%
Neumora Therapeutics, Inc. (NMRA)2025-12-31$87.18M+191.5%
Solid Biosciences Inc. (SLDB)2025-12-31$52.53M+2.2%

Compare TARA, TIL, CMPX, MGX side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗